| 000 | 01542 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514065450.0 | ||
| 264 | 0 | _c20040322 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a0918-6158 | ||
| 024 | 7 |
_a10.1248/bpb.26.687 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMurata, Yoshifumi | |
| 245 | 0 | 0 |
_aFunctions of a chitosan-orotic acid salt in the gastrointestinal tract. _h[electronic resource] |
| 260 |
_bBiological & pharmaceutical bulletin _cMay 2003 |
||
| 300 |
_a687-90 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdjuvants, Pharmaceutic _xchemistry |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdsorption |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBile Acids and Salts _xchemistry |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aChitin _xanalogs & derivatives |
| 650 | 0 | 4 | _aChitosan |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 | _aDiet |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aGastrointestinal Tract _xmetabolism |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xchemistry |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOrotic Acid _xchemistry |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aKojima, Naoko | |
| 700 | 1 | _aKawashima, Susumu | |
| 773 | 0 |
_tBiological & pharmaceutical bulletin _gvol. 26 _gno. 5 _gp. 687-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1248/bpb.26.687 _zAvailable from publisher's website |
| 999 |
_c12525422 _d12525422 |
||